These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

972 related articles for article (PubMed ID: 19202522)

  • 1. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASD/PFO devices: what is in the pipeline?
    Majunke N; Sievert H
    J Interv Cardiol; 2007 Dec; 20(6):517-23. PubMed ID: 18042057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
    Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale and left atrial appendage: new devices and methods for closure.
    Hein R; Bayard Y; Taaffe M; Büscheck F; Ostermayer S; Billinger K; Reschke M; Trepels T; Lissmann-Jensen H; Lang K; Römer A; Wilson N; Sievert H
    Pediatr Cardiol; 2005; 26(3):234-40. PubMed ID: 16132300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial and ventricular septal defects can safely be closed by percutaneous intervention.
    Hein R; Büscheck F; Fischer E; Leetz M; Bayard MT; Ostermayer S; Reschke M; Lang K; Römer A; Wilson N; Sievert H
    J Interv Cardiol; 2005 Dec; 18(6):515-22. PubMed ID: 16336434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
    Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
    BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C; Khandelwal A; Timmermanns I; Schräder R
    Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
    Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent foramen ovale and ventricular septal defect closure.
    Wahl A; Meier B
    Heart; 2009 Jan; 95(1):70-82. PubMed ID: 19047442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous treatment of patent foramen ovale and atrial septal defects.
    Tobis J; Shenoda M
    J Am Coll Cardiol; 2012 Oct; 60(18):1722-32. PubMed ID: 23040567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
    Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale.
    Earing MG; Cabalka AK; Seward JB; Bruce CJ; Reeder GS; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):24-34. PubMed ID: 14708945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-surgical closure of type-II atrial-septal defect and patent foramen ovale].
    Chatterjee T; Aeschbacher BC; Meier B
    Schweiz Med Wochenschr; 1997 Dec; 127(49):2054-60. PubMed ID: 9476306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience.
    Aytemir K; Oto A; Ozkutlu S; Kaya EB; Canpolat U; Yorgun H; Sahiner L; Kabakçi G
    J Interv Cardiol; 2012 Aug; 25(4):375-81. PubMed ID: 22612236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.